{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:20:41Z","timestamp":1770157241857,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.5664\/jcsm.9550","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T15:49:28Z","timestamp":1626796168000},"page":"235-244","source":"Crossref","is-referenced-by-count":8,"title":["Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy"],"prefix":"10.1007","volume":"18","author":[{"given":"Russell","family":"Rosenberg","sequence":"first","affiliation":[{"name":"NeuroTrials Research, Inc, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Thorpy","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[{"name":"Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, INSERM, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula K.","family":"Schweitzer","sequence":"additional","affiliation":[{"name":"Sleep Medicine and Research Center, St Luke\u2019s Hospital, Chesterfield, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Zammit","sequence":"additional","affiliation":[{"name":"Clinilabs Drug Development Corporation, New York, New York"},{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gotfried","sequence":"additional","affiliation":[{"name":"Pulmonary Associates, PA, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shay","family":"Bujanover","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Scheckner","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[{"name":"University of California, San Diego, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30198-5"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.05.009"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/25.2.197"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.15"},{"issue":"5","key":"e_1_3_3_6_2","first-page":"631","article-title":"Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy","volume":"31","author":"Sonka K","year":"2010","unstructured":"Sonka K, Kemlink D, Buskov\u00e1 J, et\u00a0al . Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy. Neuroendocrinol Lett. 2010; 31( 5): 631\u2013 634.","journal-title":"Neuroendocrinol Lett."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004060170057"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.156"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7624"},{"key":"e_1_3_3_10_2","unstructured":"Food and Drug Administration. Narcolepsy public meeting on patient-focused drug development. \n2013. Available at: \nhttps:\/\/www.fda.gov\/downloads\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/UCM377107.pdf. Accessed February 1 2019."},{"key":"e_1_3_3_11_2","unstructured":"Provigil. Package insert. North Wales PA: Teva Pharmaceuticals; 2018."},{"key":"e_1_3_3_12_2","unstructured":"Nuvigil. Package insert. North Wales PA: Teva Pharmaceuticals; 2018."},{"key":"e_1_3_3_13_2","unstructured":"Wakix. Package insert. Plymouth Meeting PA: Harmony Biosciences; 2020."},{"key":"e_1_3_3_14_2","unstructured":"Ritalin. Package insert. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2019."},{"key":"e_1_3_3_15_2","volume-title":"Xyrem\u00ae (sodium oxybate) oral solution Prescribing Information.","year":"2018","unstructured":"Xyrem\u00ae (sodium oxybate) oral solution Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals; 2018."},{"issue":"5","key":"e_1_3_3_16_2","first-page":"233","article-title":"The medical and economic burden of narcolepsy: implications for managed care","volume":"10","author":"Thorpy MJ","year":"2017","unstructured":"Thorpy MJ, Hiller G . The medical and economic burden of narcolepsy: implications for managed care. Am Health Drug Benefits. 2017; 10( 5): 233\u2013 241.","journal-title":"Am Health Drug Benefits."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.10.002"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7640"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-016-0156-0"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12039"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.6.711"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00016808"},{"key":"e_1_3_3_23_2","volume-title":"Sunosi\u2122 (solriamfetol) tablets. Prescribing Information.","year":"2019","unstructured":"Sunosi\u2122 (solriamfetol) tablets. Prescribing Information. Jazz Pharmaceuticals, Inc: Palo Alto, CA; 2019."},{"key":"e_1_3_3_24_2","volume-title":"Sunosi\u00ae (solriamfetol) tablets. Summary of Product Characteristics.","year":"2020","unstructured":"Sunosi\u00ae (solriamfetol) tablets. Summary of Product Characteristics. Dublin, Ireland: Jazz Pharmaceuticals Ireland Ltd; 2020."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1100OC"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.11.005"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25423"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz220"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz067.567"},{"key":"e_1_3_3_30_2","unstructured":"Adderall. Package insert. Horsham PA: Teva Pharmaceuticals; 2017."},{"key":"e_1_3_3_31_2","unstructured":"Dextroamphetamine sulfate. Package insert. North Wales PA: Teva Pharmaceuticals; 2016."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0337-4"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5096"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70225-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201907-1284OC"},{"key":"e_1_3_3_36_2","article-title":"Obstructive sleep apnea patients adhering to continuous positive airway pressure: a randomized trial","author":"P\u00e9pin JL","unstructured":"P\u00e9pin JL, Georgiev O, Tiholov R, et\u00a0al . Obstructive sleep apnea patients adhering to continuous positive airway pressure: a randomized trial. Chest. 2021;159(4): 1598\u20131609.","journal-title":"Chest."},{"key":"e_1_3_3_37_2","unstructured":"Excessive daytime sleepiness in obstructive sleep apnoea syndrome (OSAD) European marketing authorisation for Ozawade TM . News release. Bioprojet; September 3 2021."}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:50Z","timestamp":1770110210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.9550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.5664\/jcsm.9550"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.9550","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}